More tunnel before the light
20 November 2020
The November rally in stock markets finally petered out this week as it felt as if ‘November finally got the memo about 2020’. This was despite further positive vaccine news that bolstered optimism for next year. On Monday, US firm Moderna announced that phase 3 test results of its messenger RNA based vaccine had a 95% success rate, confirming that messenger vaccines work, after the Pfizer & BioNTech messenger vaccine – had also produced above 90% effectiveness a week earlier. The latter, two-shot vaccine, could start being given to the UK’s vulnerable people before the end of this month, with the second dose being administered three weeks later. The early recipients may achieve the prospect of a proper Christmas with their families – updated rules permitting. Meanwhile the one-shot vaccine from Oxford/AstraZeneca is likely to begin distribution just after Christmas. By March, a million people a week could be receiving immunisation in the UK.